THE University of Strathclyde has extended its partnership with drug giant GSK in an agreement worth more than £2.5 million.

The collaboration involves MPhil and PhD students working with GSK scientists to develop and conduct novel research approaches to drug discovery and therapeutic treatments. Since launching in 2009, more than 120 research students have worked on the programme, leading to the publication of nearly 50 research papers. Sixteen patents have been filed and eight students have been named inventors, the university said, adding that GSK has supported the project with funding of more than £7m.